Features of peripheral CD8⁺CD57⁺ lymphocytes in patients with autoimmune hemolytic anemia

References

• Liebman HA, Weitz IC. Autoimmune hemolytic anemia. Med Clin North Am. 2017;101:351–359.
   PubMed Web of Science ®Google Scholar
• Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014;99:1547–1554.
   PubMed Web of Science ®Google Scholar
• Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116:e35–e40.
   PubMed Web of Science ®Google Scholar
• Aladjidi N, Leverger G, Leblanc T, et al. New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica. 2011;96:655–663.
   PubMed Web of Science ®Google Scholar
• Hill QA, Stamps R, Massey E, et al. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol. 2017;176:395–411.
   PubMed Web of Science ®Google Scholar
• Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002;69:258–271.
   PubMed Web of Science ®Google Scholar
• Bass GF, Tuscano ET, Tuscano JM. Diagnosis and classification of autoimmune hemolytic anemia. Autoimmun Rev. 2014;13:560–564.
   PubMed Web of Science ®Google Scholar
• Segel GB, Lichtman MA. Direct antiglobulin (“Coombs”) test-negative autoimmune hemolytic anemia: a review. Blood Cells Mol Dis. 2014;52:152–160.
   PubMed Web of Science ®Google Scholar
• Jaime-Pérez JC, Rodríguez-Martínez M, Gómez-De-León A, et al. Current approaches for the treatment of autoimmune hemolytic anemia. Arch Immunol Ther Exp. 2013;61:385–395.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014;124:2930–2936.
   PubMed Web of Science ®Google Scholar
• Chaudhary R, Das S. Autoimmune hemolytic anemia: From lab to bedside. Asian J Transfus Sci. 2014;8:5.
   PubMedGoogle Scholar
• Barcellini W. New insights in the pathogenesis of autoimmune hemolytic anemia. Transfus Med Hemother. 2015;42:287–293.
   PubMed Web of Science ®Google Scholar
• Ahmad E, Elgohary T, Ibrahim H. Naturally occurring regulatory T cells and interleukins 10 and 12 in the pathogenesis of idiopathic warm autoimmune hemolytic anemia. J Investig Allergol Clin Immunol. 2011;21:297–304.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Konya C, Goronzy JJ, et al. Inhibitory CD8+ T cells in autoimmune disease. Hum Immunol. 2008;69:781–789.
   PubMed Web of Science ®Google Scholar
• Smirnova SJ, Sidorova JV, Tsvetaeva NV, et al. Expansion of CD8+ cells in autoimmune hemolytic anemia. Autoimmunity. 2016;49:147–154.
   PubMed Web of Science ®Google Scholar
• Strioga M, Pasukoniene V, Characiejus D. CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology. 2011;134:17–32.
   PubMed Web of Science ®Google Scholar
• Wang EC, Lawson TM, Vedhara K, et al. CD8high+ (CD57+) T cells in patients with rheumatoid arthritis. Arthritis Rheum. 1997;40:237–248.
   PubMedGoogle Scholar
• Schirmer M, Goldberger C, Würzner R, et al. Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis. Arthritis Res. 2002;4:71–76.
   PubMedGoogle Scholar
• Sun Z, Zhong W, Lu X, et al. Association of Graves' disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells. J Clin Immunol. 2008;28:464–472.
   PubMed Web of Science ®Google Scholar
• Pedroza-Seres M, Linares M, Voorduin S, et al. Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells. Br J Ophthalmol. 2007;91:1393–1398.
   PubMed Web of Science ®Google Scholar
• Tulunay A, Yavuz S, Direskeneli H, et al. CD8 + CD28-, suppressive T cells in systemic lupus erythematosus. Lupus. 2008;17:630–637.
   PubMed Web of Science ®Google Scholar
• Dammacco F, Sansonno D, Piccoli C, et al. The cryoglobulins: an overview. Eur J Clin Investig. 2001;31:628–638.
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Lang A-G, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–191.
   PubMed Web of Science ®Google Scholar
• Roumier M, Loustau V, Guillaud C, et al. Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients. Am J Hematol. 2014;89:E150–E155.
   PubMed Web of Science ®Google Scholar
• Moreno C, Hodgson K, Ferrer G, et al. Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood. 2010;116:4771–4776.
   PubMed Web of Science ®Google Scholar
• Lauletta G, Russi S, Conteduca V, et al. Hepatitis C virus infection and mixed cryoglobulinemia. Clin Dev Immunol. 2012;2012:502156.
   PubMedGoogle Scholar
• Ulvestad E, Berentsen S, Bø K, et al. Clinical immunology of chronic cold agglutinin disease. Eur J Haematol. 2009;63:259–266.
   Google Scholar
• Berentsen S, Ulvestad E, Tjønnfjord GE. B-lymphocytes as targets for therapy in chronic cold agglutinin disease. Cardiovasc Hematol Disord Drug Targets. 2007;7:219–227.
   PubMedGoogle Scholar
• Schöllkopf C, Kjeldsen L, Bjerrum OW, et al. Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients. Leuk Lymphoma. 2006;47:253–260.
   PubMed Web of Science ®Google Scholar
• Swiecicki PL, Hegerova LT, Gertz MA. Cold agglutinin disease. Blood. 2013;122:1114–1121.
   PubMed Web of Science ®Google Scholar
• Go RS, Winters JL, Kay NE. How I treat autoimmune hemolytic anemia. Blood. 2017;129:2971–2979.
   PubMed Web of Science ®Google Scholar
• McKinney EF, Lee JC, Jayne DRW, et al. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature. 2015;523:612–616.
   PubMed Web of Science ®Google Scholar
• Mercadante ER, Lorenz UM. Breaking free of control: How conventional T cells overcome regulatory T cell suppression. Front Immunol. 2016;7:193.
   PubMed Web of Science ®Google Scholar
• McKinney EF, Smith KG. T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases. Immunol Cell Biol. 2016;94:935–942.
   PubMed Web of Science ®Google Scholar
• Focosi D, Bestagno M, Burrone O, et al. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol. 2010;87:107–116.
   PubMed Web of Science ®Google Scholar
• Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711–2720.
   PubMed Web of Science ®Google Scholar
• Weng NP, Akbar AN, Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol. 2009;306–312.
   PubMed Web of Science ®Google Scholar
• Balato A, Unutmaz D, Gaspari AA. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Investig Dermatol. 2009;129:1628–1642.
   PubMed Web of Science ®Google Scholar
• Fasth AER, Dastmalchi M, Rahbar A, et al. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol. 2009;183:4792–4799.
   PubMed Web of Science ®Google Scholar
• Scarsi M, Ziglioli T, Airo P. Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response. J Rheumatol. 2010;37:911–916.
   PubMed Web of Science ®Google Scholar
• Frassanito MA, Silvestris F, Cafforio P, et al. CD8+/CD57 cells and apoptosis suppress T-cell functions in multiple myeloma. Br J Haematol. 1998;100:469–477.
   PubMed Web of Science ®Google Scholar
• Wolniak KL, Goolsby CL, Chen Y-H, et al. Expansion of a Clonal CD8 + CD57+ large granular lymphocyte population after autologous stem cell transplant in multiple myeloma. Am J Clin Pathol. 2013;139:231–241.
   PubMed Web of Science ®Google Scholar